Seven Eight Capital’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-84,392
| Closed | -$2.19M | – | 210 |
|
|
2024
Q3 | $2.19M | Sell |
84,392
-12,012
| -12% | -$299K | 0.2% | 163 |
|
|
2024
Q2 | $2.17M | Buy |
96,404
+20,743
| +27% | +$460K | 0.23% | 117 |
|
|
2024
Q1 | $1.8M | Buy |
75,661
+53,024
| +234% | +$1.18M | 0.19% | 165 |
|
|
2023
Q4 | $543K | Buy |
22,637
+872
| +4% | +$19K | 0.06% | 409 |
|
|
2023
Q3 | $476K | Buy |
21,765
+8,305
| +62% | +$174K | 0.06% | 399 |
|
|
2023
Q2 | $257K | Buy |
+13,460
| New | +$259K | 0.04% | 421 |
|
|
2022
Q4 | – | Sell |
-40,396
| Closed | -$633K | – | 478 |
|
|
2022
Q3 | $633K | Buy |
40,396
+28,663
| +244% | +$554K | 0.13% | 225 |
|
|
2022
Q2 | $244K | Sell |
11,733
-8,635
| -42% | -$178K | 0.1% | 295 |
|
|
2022
Q1 | $462K | Buy |
+20,368
| New | +$398K | 0.06% | 339 |
|
|
2021
Q2 | – | Sell |
-82,300
| Closed | -$1.65M | – | 619 |
|
|
2021
Q1 | $1.65M | Hold |
82,300
| – | – | 0.38% | 85 |
|
|
2020
Q4 | $1.65M | Buy |
+82,300
| New | +$1.72M | 0.38% | 85 |
|
|
2020
Q3 | – | Sell |
-18,100
| Closed | -$430K | – | 574 |
|
|
2020
Q2 | $430K | Buy |
18,100
+1,300
| +8% | +$30.1K | 0.31% | 110 |
|
|
2020
Q1 | $289K | Sell |
16,800
-78,411
| -82% | -$1.43M | 0.07% | 322 |
|
|
2019
Q4 | $1.68M | Sell |
95,211
-64,200
| -40% | -$1.09M | 0.09% | 338 |
|
|
2019
Q3 | $2.82M | Buy |
159,411
+8,695
| +6% | +$176K | 0.15% | 204 |
|
|
2019
Q2 | $3.22M | Sell |
150,716
-61,800
| -29% | -$1.3M | 0.17% | 174 |
|
|
2019
Q1 | $5.06M | Buy |
212,516
+196,300
| +1,211% | +$4.48M | 0.27% | 119 |
|
|
2018
Q4 | $319K | Sell |
16,216
-30,400
| -65% | -$542K | 0.02% | 470 |
|
|
2018
Q3 | $826K | Sell |
46,616
-83,400
| -64% | -$1.63M | 0.05% | 388 |
|
|
2018
Q2 | $2.8M | Buy |
130,016
+113,100
| +669% | +$2.34M | 0.19% | 162 |
|
|
2018
Q1 | $375K | Sell |
16,916
-151,494
| -90% | -$4.19M | 0.03% | 289 |
|
|
2017
Q4 | $5.12M | Buy |
+168,410
| New | +$4.48M | 0.52% | 48 |
|
|
2017
Q3 | – | Sell |
-48,987
| Closed | -$1.21M | – | 502 |
|
|
2017
Q2 | $1.21M | Buy |
48,987
+36,107
| +280% | +$764K | 0.17% | 182 |
|
|
2017
Q1 | $279K | Sell |
12,880
-71,000
| -85% | -$1.44M | 0.05% | 340 |
|
|
2016
Q4 | $1.25M | Buy |
+83,880
| New | +$1.21M | 0.25% | 150 |
|
|
2016
Q3 | – | Sell |
-13,400
| Closed | -$105K | – | 409 |
|
|
2016
Q2 | $105K | Buy |
+13,400
| New | +$77.2K | 0.04% | 397 |
|
Other funds holding EXEL
FCM
Seven Eight Capital's EXEL Position: Q4 2024 in Review
Seven Eight Capital sold out of Exelixis (EXEL) in Q4 2024, closing a stake of 84,392 shares — an estimated $2.19M sold.
Seven Eight Capital first reported a position in EXEL in Q2 2016 and held it in 26 quarters. The position peaked at $5.12M in Q4 2017. 518 funds tracked by Wall St. Rank hold EXEL as of Q4 2024.
- Seven Eight Capital reported no remaining Exelixis position as of Q4 2024 after selling out during the quarter.
- Seven Eight Capital sold 84,392 Exelixis shares in Q4 2024, an estimated $2.19M.
- Seven Eight Capital first reported a position in Exelixis in Q2 2016 and held it in 26 quarters.
- Seven Eight Capital's Exelixis position peaked at $5.12M in Q4 2017.
- 518 funds tracked by Wall St. Rank held Exelixis as of Q4 2024.
Based on Seven Eight Capital's 13F filing for Q4 2024.